NEW YORK (GenomeWeb News) – Johnson & Johnson Pharmaceutical Research and Development has extended a licensing agreement for BioWisdom’s OmniViz visualization and data-mining software, BioWisdom said today.

BioWisdom merged with OmniViz early last year.

The OmniViz software offers visualization of text, numerical, and categorical data as well as genome sequences, chemical structures, and text files.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.